HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Thomas Walther Ardawan Rastan Volkmar Falk Friedrich W. Mohr Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lehmann, S. Articles by Mohr, F. W. Search for Related Content PubMed PubMed Citation Articles by Lehmann, S. Articles by Mohr, F. W. Related Collections Valve disease

Ann Thorac Surg 2007;84:467-472
© 2007 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Stentless Versus Conventional Xenograft Aortic Valve Replacement: Midterm Results of a Prospectively Randomized Trial

Department of Cardiac Surgery, Heartcenter, University of Leipzig, Leipzig, Germany

Accepted for publication February 6, 2007.

^_* Address correspondence to Dr Walther, Universität Leipzig, Herzzentrum, Klinik für Herzchirurgie, Strümpellstr 39, Leipzig 04289, Germany (Email: walt{at}medizin.uni-leipzig.de).

Background: The purpose of this study was to analyze the 5- to 8-year clinical results after prospectively randomized stentless versus conventional aortic valve replacement.

Methods: Two hundred twenty-three patients received stentless (Freestyle or Toronto, n = 127) or conventional stented (CE porcine, n = 96) xenograft aortic valve replacement between March 1996 and March 1999 using a prospectively randomized protocol and were discharged from the hospital. Patient age at operation was 71.8 ± 6.7 years stentless and 74.9 ± 4 years stented (p < 0.05). There were no significant differences regarding preoperative morphologic and hemodynamic variables. Aortic annulus diameter indices were comparable at 13.5 mm stentless and 13.6 mm stented. Follow-up after 6.9 ± 0.8 years is complete for 95.6% of the patients at a total of 1,533 patient-years. Analysis of variance, unpaired t test, univariate (²), and survival analysis (log rank) were performed.

Results: Eight-year survival was 78.1% ± 3.8% stentless versus 66% ± 4.9% stented (p = 0.04); mean survival was 97 months stentless versus 88 months stented. At most recent follow-up, New York Heart Association functional class was 1.6 ± 0.6 stentless versus 1.5 ± 0.7 stented (p = not significant); ejection fraction was 61% ± 11% versus 61% ± 8% (p = not significant); transvalvular maximum flow velocity was 23 ± 9 mm Hg versus 37 ± 15 mm Hg (p < 0.01). Thrombembolic events occurred in 2 of 7 patients, including 2 of 6 patients suffering major stroke (p = not significant). Most (93%) of the patients were satisfied with the postoperative course, having a significantly improved quality of life.

Conclusions: Midterm results after xenograft aortic valve replacement are satisfactory. Overall survival is significantly better after stentless aortic valve replacement in this series. However, there was no cause and effect relationship between lower transvalvular pressure gradient. Fewer thrombembolic events and better survival rates were proven.

This article has been cited by other articles:

				H. Gulbins and H. Reichenspurner Which patients benefit from stentless aortic valve replacement? Ann. Thorac. Surg., December 1, 2009; 88(6): 2061 - 2068. [Abstract] [Full Text] [PDF]

				S. Lehmann, T. Walther, J. Kempfert, A. Rastan, J. Garbade, S. Dhein, and F. W. Mohr Mechanical strain and the aortic valve: influence on fibroblasts, extracellular matrix, and potential stenosis. Ann. Thorac. Surg., November 1, 2009; 88(5): 1476 - 1483. [Abstract] [Full Text] [PDF]

				S. Lehmann, T. Walther, S. Leontyev, J. Kempfert, J. Garbade, M. A. Borger, and F. W. Mohr The Toronto Root Bioprosthesis: Midterm Results in 186 Patients. Ann. Thorac. Surg., June 1, 2009; 87(6): 1751 - 1756. [Abstract] [Full Text] [PDF]

				S. Leontyev, T. Walther, M. A. Borger, S. Lehmann, A. K. Funkat, A. Rastan, J. Kempfert, V. Falk, and F. W. Mohr Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann. Thorac. Surg., May 1, 2009; 87(5): 1440 - 1445. [Abstract] [Full Text] [PDF]

				P. S. Risteski, S. Martens, A. Rouhollahpour, G. Wimmer-Greinecker, A. Moritz, and M. Doss Prospective randomized evaluation of stentless vs. stented aortic biologic prosthetic valves in the elderly at five years Interactive CardioVascular and Thoracic Surgery, April 1, 2009; 8(4): 449 - 453. [Abstract] [Full Text] [PDF]

				E. Balaras, K.S. Cha, B. P. Griffith, and J. S. Gammie Treatment of aortic stenosis with aortic valve bypass (apicoaortic conduit) surgery: an assessment using computational modeling. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 680 - 687. [Abstract] [Full Text] [PDF]

				R. Di Bartolomeo, L. Botta, A. Leone, E. Pilato, S. Martin-Suarez, M. Bacchini, and D. Pacini Bio-ValsalvaTM prosthesis: 'new' conduit for 'old' patients Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1062 - 1066. [Abstract] [Full Text] [PDF]

				J. S. Gammie, L. S. Krowsoski, J. M. Brown, P. N. Odonkor, C. A. Young, M. J. Santos, J. S. Gottdiener, and B. P. Griffith Aortic Valve Bypass Surgery: Midterm Clinical Outcomes in a High-Risk Aortic Stenosis Population Circulation, September 30, 2008; 118(14): 1460 - 1466. [Abstract] [Full Text] [PDF]